The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma
Background and Aim. Identification of sensitive biomarkers to improve early diagnosis of HCC is needed. We aimed to evaluate serum midkine (MDK) as a biomarker for HCC diagnosis. Patients and Methods. 40 HCCs, 30 liver cirrhosis patients, and 30 healthy subjects were enrolled. Serum MDK using ELISA...
Main Authors: | Karim Y. A. Shaheen, Abeer I. Abdel-Mageed, Eslam Safwat, Ashraf M. AlBreedy |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2015/146389 |
Similar Items
-
Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma
by: Hossam Hodeib, et al.
Published: (2017-01-01) -
Serum midkine levels for the diagnosis and assessment of response to interventional therapy in patients with hepatocellular carcinoma
by: Lin Zheng, et al.
Published: (2021-02-01) -
Diagnostic accuracy of midkine on hepatocellular carcinoma: A meta-analysis.
by: Bo-Han Zhang, et al.
Published: (2019-01-01) -
Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta‐analysis
by: Yu Zhang, et al.
Published: (2020-02-01) -
The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica
by: Milad Moayednia, et al.
Published: (2021-03-01)